<DOC>
	<DOC>NCT01395069</DOC>
	<brief_summary>Assess prophylactic efficacy of topical non-steroidal anti-inflammatory drops in preventing macular edema. Patient undergoing uncomplicated cataract surgery will be enrolled and randomized to nepafenac, ketorolac, or placebo. Follow-up will occur at 1 month with ocular coherence tomography (OCT).</brief_summary>
	<brief_title>Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<criteria>Ability to give informed consent Age 18 years and older Any preexisting retinal disease (e.g., diabetic retinopathy, vein occlusion, exudative macular degeneration, etc.) Previous uveitis Previous intraocular surgery Allergy or hypersensitivity to NSAIDs Complicated cataract surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Post-cataract surgery</keyword>
	<keyword>macular edema</keyword>
</DOC>